Daniel Bazarko Alexion Pharmaceuticals, Inc. (ALXN) insider trading activity

Daniel Bazarko is SVP, Controller, CAO of ALEXION PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of ALXN, which is worth approximately $0. The most recent transaction as insider was on Jul 21, 2021, when has been sold 60,207 shares (Common Stock, par value $.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Daniel Bazarko Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 21 2021	SELL Sale (or disposition) back to the issuer	-	60,207 Reduced 100.0%	0 Common Stock, par valu...
Jul 14 2021	BUY Grant, award, or other acquisition	-	21,708 Added 26.5%	60,207 Common Stock, par valu...
Feb 28 2021	BUY Grant, award, or other acquisition	-	7,616 Added 16.52%	38,499 Common Stock, par valu...
Dec 17 2020	SELL Open market or private sale	$3,797,133 $157.78 p/Share	24,066 Reduced 43.8%	30,883 Common Stock, par valu...
Dec 17 2020	BUY Exercise of conversion of derivative security	$2,860,725 $118.87 p/Share	24,066 Added 30.46%	54,949 Common Stock, par valu...
Dec 16 2020	SELL Payment of exercise price or tax liability	$1,391,944 $157.96 p/Share	8,812 Reduced 22.2%	30,883 Common Stock, par valu...
Dec 16 2020	BUY Grant, award, or other acquisition	-	15,371 Added 27.91%	39,695 Common Stock, par valu...

Daniel Bazarko

SVP, Controller, CAO

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALXN shares.

Notify only if

Value

Insider Trading

Get notified when an Alexion Pharmaceuticals, Inc. insider buys or sells ALXN shares.

Notify only if

Operation

Value

Type

News

Receive news related to ALEXION PHARMACEUTICALS, INC.

Track Activities on ALXN

Account